CA2574985A1 - Composition renfermant de la theanine - Google Patents
Composition renfermant de la theanine Download PDFInfo
- Publication number
- CA2574985A1 CA2574985A1 CA002574985A CA2574985A CA2574985A1 CA 2574985 A1 CA2574985 A1 CA 2574985A1 CA 002574985 A CA002574985 A CA 002574985A CA 2574985 A CA2574985 A CA 2574985A CA 2574985 A1 CA2574985 A1 CA 2574985A1
- Authority
- CA
- Canada
- Prior art keywords
- composition according
- composition
- symptom
- homeostasis
- symptom accompanying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract 16
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 title claims abstract 6
- 229940026510 theanine Drugs 0.000 title claims abstract 3
- 208000024891 symptom Diseases 0.000 claims abstract 10
- 230000003292 diminished effect Effects 0.000 claims abstract 8
- 230000013632 homeostatic process Effects 0.000 claims abstract 8
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract 3
- 239000011707 mineral Substances 0.000 claims abstract 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims 2
- 206010003840 Autonomic nervous system imbalance Diseases 0.000 claims 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims 1
- 208000017657 Menopausal disease Diseases 0.000 claims 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 claims 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims 1
- 206010036618 Premenstrual syndrome Diseases 0.000 claims 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 1
- 230000000338 anxiogenic effect Effects 0.000 claims 1
- 229910052791 calcium Inorganic materials 0.000 claims 1
- 239000011575 calcium Substances 0.000 claims 1
- 229910052804 chromium Inorganic materials 0.000 claims 1
- 239000011651 chromium Substances 0.000 claims 1
- 229910052802 copper Inorganic materials 0.000 claims 1
- 239000010949 copper Substances 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims 1
- 229910052742 iron Inorganic materials 0.000 claims 1
- 239000011777 magnesium Substances 0.000 claims 1
- 229910052749 magnesium Inorganic materials 0.000 claims 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims 1
- 229910052750 molybdenum Inorganic materials 0.000 claims 1
- 239000011733 molybdenum Substances 0.000 claims 1
- 229910052759 nickel Inorganic materials 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 229910052700 potassium Inorganic materials 0.000 claims 1
- 239000011591 potassium Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 229910052711 selenium Inorganic materials 0.000 claims 1
- 239000011669 selenium Substances 0.000 claims 1
- 230000035945 sensitivity Effects 0.000 claims 1
- 208000019116 sleep disease Diseases 0.000 claims 1
- 208000020685 sleep-wake disease Diseases 0.000 claims 1
- 229910052720 vanadium Inorganic materials 0.000 claims 1
- LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical compound [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 claims 1
- 239000011701 zinc Substances 0.000 claims 1
- 229910052725 zinc Inorganic materials 0.000 claims 1
- 239000002184 metal Substances 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP05747098A JP2001089365A (ja) | 1998-02-23 | 1998-02-23 | 不安惹起抑制組成物 |
| JP10/57470 | 1998-02-23 | ||
| JP10/142119 | 1998-05-08 | ||
| JP14211998A JP4350814B2 (ja) | 1998-05-08 | 1998-05-08 | ミネラル組成物 |
| JP10/234968 | 1998-08-06 | ||
| JP23496898A JP4402756B2 (ja) | 1998-08-06 | 1998-08-06 | 肥満抑制組成物 |
| JP10/330207 | 1998-11-05 | ||
| JP33020798A JP4971535B2 (ja) | 1998-11-05 | 1998-11-05 | 月経前症候群抑制組成物 |
| CA002320368A CA2320368C (fr) | 1998-02-23 | 1999-02-23 | Composition renfermant de la theanine |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002320368A Division CA2320368C (fr) | 1998-02-23 | 1999-02-23 | Composition renfermant de la theanine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2574985A1 true CA2574985A1 (fr) | 1999-08-26 |
| CA2574985C CA2574985C (fr) | 2010-04-27 |
Family
ID=37890084
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2574985A Expired - Lifetime CA2574985C (fr) | 1998-02-23 | 1999-02-23 | Composition renfermant de la theanine |
| CA2574984A Expired - Lifetime CA2574984C (fr) | 1998-02-23 | 1999-02-23 | Composition renfermant de la theanine |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2574984A Expired - Lifetime CA2574984C (fr) | 1998-02-23 | 1999-02-23 | Composition renfermant de la theanine |
Country Status (1)
| Country | Link |
|---|---|
| CA (2) | CA2574985C (fr) |
-
1999
- 1999-02-23 CA CA2574985A patent/CA2574985C/fr not_active Expired - Lifetime
- 1999-02-23 CA CA2574984A patent/CA2574984C/fr not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2574985C (fr) | 2010-04-27 |
| CA2574984A1 (fr) | 1999-08-26 |
| CA2574984C (fr) | 2010-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2320368A1 (fr) | Composition renfermant de la theanine | |
| SE9802763D0 (sv) | Liquid oral compositions comprising a calcium compound and an acidulant | |
| CA2395372A1 (fr) | Compositions d'additif alimentaire en suspension et compositions alimentaires les contenant | |
| WO2003045328A3 (fr) | Procedes de fabrication et d'utilisation de theaflavine, de theaflavine-3-gallate, de theaflavine-3'-gallage et de theaflavine 3,3'-digallate et des melanges de ceux-ci | |
| CA2574985A1 (fr) | Composition renfermant de la theanine | |
| BR0011527A (pt) | Método e composição para mascarar o sabor de minerais | |
| CA2209848A1 (fr) | Composition pharmaceutique ou dietetique contenant des ions de sodium, potassium, magnesium et de calcium et des activateurs d'enzymes | |
| BR0001914A (pt) | Compostos flavorizantes | |
| GB2364498A (en) | Composition comprising an alpha-amylase inhibitor and at least one physiologically acceptable compound capable of reducing intestinal absorption | |
| HK1048500B (zh) | 耐脫鋅的壓鑄黃銅合金 | |
| TW200420294A (en) | Methods of making and using theaflavin, thealflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3, 3'-digallate and mixtures thereof | |
| WO2001003325A3 (fr) | Utilisation de creatine ou de derives de creatine pour le traitement de troubles de l'etat de sante chez la femme | |
| Phanish et al. | Colchicine-induced rhabdomyolysis | |
| ATE144992T1 (de) | Antihypertonika und lebensmittel und getränke, die solche antihypertonika enthalten | |
| SU1342939A1 (ru) | Сталь | |
| 吕其昌 et al. | The US Policy Readjustment towards Russia | |
| RU2000120689A (ru) | Сталь | |
| SU306183A1 (ru) | Износостойкий сплав на железной основе | |
| SU1548237A1 (ru) | Сплав дл раскислени и микролегировани стали | |
| Maslenkov et al. | Corrosion resistant steels of Russia, USA, Germany, Japan and other countries. Part II. Ferrite steels | |
| SU1028735A1 (ru) | Чугун | |
| GB9929840D0 (en) | Detergent compositions | |
| SU1325102A1 (ru) | Сталь | |
| Baylis | Hypertension (HT) with chronic nitric oxide blockade (NOB) | |
| RU2000131069A (ru) | Фрикционный порошковый материал |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKEX | Expiry |
Effective date: 20190225 |